Due to the presence of a potential carcinogen, the FDA has announced a recall of losartan potassium tablets manufactured by India-based Hetero Labs.Original Article
Losartan Recall: Blood Pressure Medicine Impurity Linked To Cancer
You may also like
A Temporary Extension for the Rare Pediatric Disease...
Survey Says 25% Of Adults In U.S Suspect They Have...
Your Child’s Bedtime Affects Their Gut Health:...
Quality, Not Quantity Of Good Cholesterol Linked To...
Atueyi Tasks Pharmacy Students on Critical Thinking
Best Oil Cleansers: Top Solutions For Deep Cleansing...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.